U.S. Navy to randomly test special operations forces for drugs, starting in November, to ensure health and readiness, led by Rear Adm. Keith Davids.

Random testing begins in the Navy, and the Army Special Operations Command will follow later.

Special forces face pressure to use performance-enhancing drugs despite being a minor issue within the military.

Pentagon-approved policy change allows routine and random testing.

Monthly tests will impact about 200 sailors, with positive results leading to removal or disciplinary action.

Change follows the 2022 death of a Navy SEAL candidate and concerns about drug use in elite commando training.

Testing affects 9,000 active-duty personnel and reservists on active duty.

U.S. Navy allocates $225,000, expecting an annual cost of $4.5 million for two years to ensure long-term health in the Naval Special Warfare Community.

Click Here